genetically engineered humanized anti-IgE murine mAb (Sixal)

N/A

Report date: 2025/03/20 16:01:08

Base Information

Drug Namegenetically engineered humanized anti-IgE murine mAb (Sixal)

Drug Alias Namep6.2

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine

Mechanisms of ActionImmunoglobulin E inhibitors

TargetsImmunoglobulin E

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAlgeria

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSixal Corp

China Registration ClassN/A

Develop Information

Active CompaniesSixal Corp

Inactive CompaniesN/A

Active IndicationsHypersensitivity

Inactive IndicationsN/A

Other Information

ATC CodeN/A